Key Record Dates
ClinicalTrials.gov Identifier: | NCT04793958 |
---|---|
Brief Title: | Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) |
First Submitted : | March 2, 2021 |
First Submitted that Met QC Criteria : | March 8, 2021 |
First Posted : | March 11, 2021 |
Last Update Submitted that Met QC Criteria : | March 12, 2024 |
Last Update Posted : | March 15, 2024 |